BMS

Views & Analysis
The future of real world evidence

The future of real world evidence

Increasing interest in real-world evidence (RWE) across all stakeholder groups has the industry buzzing about its current role in clinical trials and the potential impact of expanded use.

Views & Analysis
2019-Review-16x9-Sales&-Marketing-1

2019: the year of the pharma mega-merger

2019 will be remembered as the year of the pharma mega-merger. Richard Staines looks back at a year that changed the landscape of big pharma